O62725
Gene name |
PTGS2 (COX2) |
Protein name |
Prostaglandin G/H synthase 2 |
Names |
Cyclooxygenase-2, COX-2, PHS II, Prostaglandin H2 synthase 2, PGH synthase 2, PGHS-2, Prostaglandin-endoperoxide synthase 2 |
Species |
Neovison vison (American mink) (Mustela vison) |
KEGG Pathway |
|
EC number |
1.14.99.1: Miscellaneous |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for O62725
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-O62725-F1 | Predicted | AlphaFoldDB |
No variants for O62725
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for O62725 | |||||
No associated diseases with O62725
1 regional properties for O62725
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | EGF-like domain | 17 - 55 | IPR000742 |
Functions
| Description | ||
|---|---|---|
| EC Number | 1.14.99.1 | Miscellaneous |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| endoplasmic reticulum membrane | The lipid bilayer surrounding the endoplasmic reticulum. |
| nuclear inner membrane | The inner, i.e. lumen-facing, lipid bilayer of the nuclear envelope. |
| nuclear outer membrane | The outer, i.e. cytoplasm-facing, lipid bilayer of the nuclear envelope; continuous with the endoplasmic reticulum of the cell and sometimes studded with ribosomes. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| dioxygenase activity | Catalysis of an oxidation-reduction (redox) reaction in which both atoms of oxygen from one molecule of O2 are incorporated into the (reduced) product(s) of the reaction. The two atoms of oxygen may be distributed between two different products. [DOI:10.1016/S0040-4020(03)00944-X, GOC:bf] |
| heme binding | Binding to a heme, a compound composed of iron complexed in a porphyrin (tetrapyrrole) ring. |
| metal ion binding | Binding to a metal ion. |
| peroxidase activity | Catalysis of the reaction: a donor + a peroxide = an oxidized donor + 2 H2O. |
| prostaglandin-endoperoxide synthase activity | Catalysis of the reaction: arachidonate + donor-H2 + 2 O2 = prostaglandin H2 + acceptor + H2O. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| cyclooxygenase pathway | The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2. |
| inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| prostaglandin biosynthetic process | The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring. |
| regulation of blood pressure | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
| regulation of neuroinflammatory response | Any process that modulates the frequency, rate or extent of neuroinflammatory response. |
| response to oxidative stress | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MLARAGLLCA | SLSPPHAANP | CCSNPCQNQG | VCMSIGFDQY | MCDCSRTGFY | GENCSTPEFL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| TRVKLLLKPT | PNTVHYILTH | FKGVWNIVNK | IPFLADVIMK | YVRTSRSHCI | EPPPTYNVHY |
| 130 | 140 | 150 | 160 | 170 | 180 |
| AYKSWEAFSN | LSYYTRALPP | VADDCPTPMG | VKGKKELPDS | KEIVEKFLLR | RKFIPDPQGT |
| 190 | 200 | 210 | 220 | 230 | 240 |
| NMMFAFFAQH | FTHQFFKTDH | KRGPGFTKGL | GHGVDLSHVY | GETLDRQHKL | RLFKDGKMKY |
| 250 | 260 | 270 | 280 | 290 | 300 |
| QVIDGEVYPP | TVKDTQVEMI | YPPHVPEHLR | FAVGQEVFGL | VPGLMMYATI | WLREHNRVCD |
| 310 | 320 | 330 | 340 | 350 | 360 |
| VLKQEQGEWD | DERLFRRSRL | ILIGETIKIV | IEDYVRHLSG | YHFSLKFDPE | LLFNQQFQYQ |
| 370 | 380 | 390 | 400 | 410 | 420 |
| NRIAAEFNTL | YHWHPLLPDT | LQIDDQEYNF | QQFVYNNSIL | LEHGLTQFGE | SFSRQIAGRV |
| 430 | 440 | 450 | 460 | 470 | 480 |
| AGGRNVPAAV | QQEQRASIDQ | SRQMKYQSLN | EYRKRFSVKP | YASFEELTGE | KEMAGELKAL |
| 490 | 500 | 510 | 520 | 530 | 540 |
| YQDIDAMELY | PALLVEKPRP | DAIFGETMVE | IGAPFSLKGL | MGNPICSPDY | WKPSHFGGEV |
| 550 | 560 | 570 | 580 | 590 | 600 |
| GFKIINTASI | QSLICNNVKG | CPFTAFSVQD | PQLTKTVTIN | GSSSHSGLDD | INPTVLLKER |
| STEL |